| Net Cash Provided by (Used in) Operating Activities |
2.03B |
USD |
+162% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Financing Activities |
-1.66B |
USD |
-456% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Investing Activities |
738M |
USD |
|
Q1 2025 |
Q1 2025 |
| Common Stock, Shares Authorized |
2.55B |
shares |
0% |
Q4 2024 |
FY 2024 |
| Common Stock, Par or Stated Value Per Share |
1.6 |
USD/shares |
0% |
Q4 2024 |
FY 2024 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
1.08B |
USD |
|
Q1 2025 |
Q1 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
5.67B |
USD |
+86% |
Q3 2025 |
Q3 2025 |
| Deferred Tax Assets, Valuation Allowance |
4.36B |
USD |
-6.21% |
Q4 2024 |
FY 2024 |
| Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent |
0.21 |
pure |
0% |
Q3 2025 |
Q3 2025 |
| Deferred Tax Assets, Gross |
6.36B |
USD |
-13% |
Q4 2024 |
FY 2024 |
| Operating Lease, Liability |
87M |
USD |
-17.1% |
Q4 2024 |
FY 2024 |
| Comprehensive Income (Loss), Net of Tax, Attributable to Parent |
7.28B |
USD |
+99.7% |
Q3 2025 |
Q3 2025 |
| Lessee, Operating Lease, Liability, to be Paid |
99M |
USD |
-17.5% |
Q4 2024 |
FY 2024 |
| Lessee, Operating Lease, Liability, to be Paid, Year Two |
14M |
USD |
-12.5% |
Q4 2024 |
FY 2024 |
| Lessee, Operating Lease, Liability, to be Paid, Year One |
20M |
USD |
-16.7% |
Q4 2024 |
FY 2024 |
| Operating Lease, Weighted Average Discount Rate, Percent |
0.04 |
pure |
+26.5% |
Q4 2024 |
FY 2024 |
| Deferred Income Tax Expense (Benefit) |
125M |
USD |
+136% |
Q1 2025 |
Q1 2025 |
| Lessee, Operating Lease, Liability, Undiscounted Excess Amount |
12M |
USD |
-20% |
Q4 2024 |
FY 2024 |
| Lessee, Operating Lease, Liability, to be Paid, Year Three |
13M |
USD |
-7.14% |
Q4 2024 |
FY 2024 |
| Unrecognized Tax Benefits |
111M |
USD |
-22.9% |
Q4 2024 |
FY 2024 |
| Lessee, Operating Lease, Liability, to be Paid, Year Four |
11M |
USD |
-15.4% |
Q4 2024 |
FY 2024 |
| Depreciation, Depletion and Amortization |
2.55B |
USD |
-0.9% |
Q3 2025 |
Q3 2025 |
| Deferred Tax Assets, Net of Valuation Allowance |
2B |
USD |
-24.8% |
Q4 2024 |
FY 2024 |
| Share-based Payment Arrangement, Expense |
21M |
USD |
0% |
Q1 2025 |
Q1 2025 |